TITLE

Safety and Adverse Effects of Androgens: How to Counsel Patients

AUTHOR(S)
Basaria, Shehzad; Dobs, Adrian S.
PUB. DATE
April 2004
SOURCE
Mayo Clinic Proceedings;Apr2004 Supplement, Vol. 79 Issue 4, pS25
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recently, interest has grown in the use of androgen replacement therapy for postmenopausal women. Androgen replacement in women improves libido, bone density, and body composition. The adverse effects, like hirsutism, are generally mild, and the safety profile of transdermal testosterone replacement is more favorable than that of other modes of androgen therapy. Further studies may help to determine the effect of lipid changes on cardiac outcomes. We believe that long-term studies are necessary to observe the potential effect of androgen replacement on cardiovascular mortality, breast and endometrial tissues, and mood and anger before this therapy can be used routinely in women.
ACCESSION #
12733983

 

Related Articles

  • Estrogen/androgen therapy increases bone formation in women. Raisz, Lawrence G. // American Family Physician;3/1/1995, Vol. 51 Issue 4, p894 

    Highlights the study presented by Lawrence G. Raisz at the meeting of the North American Menopause Society. Effects of combination estrogen-androgen therapy on bone resorption and formation in menopausal women; Markers for bone resorption and formation.

  • Related factors in bone mineral density of lumbal and femur in natural postmenopausal women. Hassa, Hikmet; Tanir, H. Mete; Senses, Tanser; Oge, Tufan; Sahin-Mutlu, Fezan // Archives of Gynecology & Obstetrics;Dec2005, Vol. 273 Issue 2, p86 

    Objective: To assess possible factors affecting the bone mineral density (BMD) in postmenopausal women. Methods: A retrospective analysis of 267 cases with spontaneous menopause within 3 years of period was performed. None of the enrolled cases were taken any hormone replacement therapy and/or...

  • Genistein increases BMD in postmenopausal women.  // Contemporary OB/GYN;Sep2007, Vol. 52 Issue 9, p22 

    The article discusses research being done on the benefits of isoflavone phytoestrogen genistein in postmenopausal women. It references a study by H. Marini, et al published in the 2007 issue of "Annals of Internal Medicine." According to the article, results indicate that treatment with...

  • New drugs, new ideas have quickly changed therapy. Guthrie, Ellen Whipple // Pharmacy Today;Jul2004, Vol. 10 Issue 7, p14 

    Hormone replacement therapy (HRT) has long been considered the mainstay of therapy for the prevention and treatment of osteoporosis in women. However, findings from HRT trials conducted as part of the Women's Health Initiative raised serious questions about the safety of HRT, and, today, it is...

  • Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from... Hemminski, Elina; McPherson, Klim // BMJ: British Medical Journal (International Edition);07/19/97, Vol. 315 Issue 7101, p149 

    Examines the incidence of cardiovascular diseases and cancer in women from clinical trials discussing outcomes of postmenopausal hormone therapy. Comparison of hormone therapy with placebo; Definition of hormone therapy; Trials studying the effects of estrogens; Impact of hormones on various...

  • Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? Posthuma, Ward F.M.; Westendorp, Rudi G.J.; Vandenbroucke, Jan P. // BMJ: British Medical Journal (International Edition);5/14/94, Vol. 308 Issue 6939, p1268 

    Examines the cardioprotective effect of hormone replacement therapy in postmenopausal women. Comparison on relative risks between cardiovascular disease and cancer; Benefits of hormone replacement therapy; Implications on the administration of oestrogen replacement therapy.

  • Hormone replacement theory: Unanswered questions, still. Rodgers, Katie // Drug Topics;5/9/94, Vol. 138 Issue 9, p32 

    Reports on the importance of hormone replacement therapy for postmenopausal women. Cardiovascular effects; Leading causes of death of women in the United States; Loss of cardioprotective effect in older women; Health risks.

  • Limitations of bone densitometry. Heidrich, Fred // American Family Physician;7/1/1993, Vol. 48 Issue 1, p25 

    Editorial. Discusses the limitations of bone densitometry. Role of bone densitometry in preventive medicine for perimenopausal women; Reliability of bone densitometry in assessing hip fracture risks; Reliability of bone density as an indicator in hormone replacement therapy; Implications.

  • Will low-dose estrogen prevent bone loss? D.R.M. // Cortlandt Forum;9/25/96, Vol. 9 Issue 9, p80 

    Reports on results of studies showing that bone loss in postmenopausal women can be prevented with estrogen replacement alone. Dosage; Reason for adding progestin to the treatment regimen.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics